Combination of an HMG-COA reductase inhibitor and a Farnesyl-pyrophosphatase synthase inhibitor for the treatment of diseases related to the persistence and/or accumulation of prenylated proteins

dc.contributor.author	Levy, Nicolas
dc.contributor.author	Cau, Pierre
dc.contributor.author	López Otín, Carlos
dc.date.accessioned	2017-07-10T06:00:48Z
dc.date.available	2017-07-10T06:00:48Z
dc.date.issued	2015-09-23
dc.identifier.uri	http://hdl.handle.net/10651/43239
dc.subject.other	A61K31/215
dc.subject.other	A61K31/22
dc.subject.other	A61K31/663
dc.subject.other	A61K31/675
dc.subject.other	A61K31/22
dc.subject.other	A61K2300/00
dc.subject.other	A61K31/663
dc.subject.other	A61K2300/00
dc.title	Combination of an HMG-COA reductase inhibitor and a Farnesyl-pyrophosphatase synthase inhibitor for the treatment of diseases related to the persistence and/or accumulation of prenylated proteins
dc.type	patent	spa
dc.date.priority	2007-07-05
dc.description.assignee	Assistance Publique Hôpitaux de Marseille
dc.description.assignee	Université D’ Aix Marseille
dc.description.assignee	Ass Fr Contre les Myopathies
dc.description.assignee	Universidad de Oviedo
dc.applnumber	PT20070803849T
dc.number	PT2034985 (E)
dc.subject.udc	A61K31/22
dc.subject.udc	A61K31/675
dc.subject.udc	A61P17/00
dc.subject.udc	A61P43/00

Files in this item

Files	Size	Format	View
There are no files associated with this item.